TrialClinical drug investigation2020

Phase I, First-in-Human, Single and Multiple Ascending Dose- and Food-Effect Studies to Assess the Safety, Tolerability and Pharmacokinetics of a Novel Anti-hepatitis B Virus Drug, Bentysrepinine (Y101), in Healthy Chinese Subjects.

Xiaoxue Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.